Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$2.89 - $5.34 $26,299 - $48,594
-9,100 Reduced 46.7%
10,385 $54,000
Q3 2023

Nov 09, 2023

BUY
$2.8 - $4.94 $54,558 - $96,255
19,485 New
19,485 $64,000
Q2 2022

Aug 11, 2022

SELL
$6.82 - $13.82 $48,988 - $99,269
-7,183 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$11.65 - $15.28 $58,250 - $76,400
-5,000 Reduced 41.04%
7,183 $101,000
Q4 2021

Feb 11, 2022

BUY
$12.37 - $16.77 $150,703 - $204,308
12,183 New
12,183 $177,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $659M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.